Follow
Rongjun He
Rongjun He
Research Scientist, Novo Nordisk
Verified email at iu.edu
Title
Cited by
Cited by
Year
Protein tyrosine phosphatases as potential therapeutic targets
R He, Z Yu, R Zhang, Z Zhang
Acta pharmacologica sinica 35 (10), 1227-1246, 2014
3512014
Phosphonium Salts as Chiral Phase‐Transfer Catalysts: Asymmetric Michael and Mannich Reactions of 3‐Aryloxindoles
R He, C Ding, K Maruoka
Angewandte Chemie International Edition 48 (25), 4559-4561, 2009
2872009
Enantioselective base-free phase-transfer reaction in water-rich solvent
R He, S Shirakawa, K Maruoka
Journal of the American Chemical Society 131 (46), 16620-16621, 2009
2292009
Binaphthyl‐Modified Quaternary Phosphonium Salts as Chiral Phase‐Transfer Catalysts: Asymmetric Amination of β‐Keto Esters
R He, X Wang, T Hashimoto, K Maruoka
Angewandte Chemie International Edition 47 (49), 9466-9468, 2008
2272008
Small molecule tools for functional interrogation of protein tyrosine phosphatases
R He, LF Zeng, Y He, S Zhang, ZY Zhang
The FEBS journal 280 (2), 731-750, 2013
1502013
Peptide conjugates with small molecules designed to enhance efficacy and safety
R He, B Finan, JP Mayer, RD DiMarchi
Molecules 24 (10), 1855, 2019
1022019
Diastereo-and enantioselective conjugate addition of α-substituted nitroacetates to maleimides under base-free neutral phase-transfer conditions
S Shirakawa, SJ Terao, R He, K Maruoka
Chemical communications 47 (38), 10557-10559, 2011
802011
Polymer‐Supported Hantzsch 1, 4‐Dihydropyridine Ester: An Efficient Biomimetic Hydrogen Source
R He, PH Toy, Y Lam
Advanced Synthesis & Catalysis 350 (1), 54-60, 2008
622008
Exploring the existing drug space for novel pTyr mimetic and SHP2 inhibitors
R He, ZH Yu, RY Zhang, L Wu, AM Gunawan, BS Lane, JS Shim, LF Zeng, ...
ACS medicinal chemistry letters 6 (7), 782-786, 2015
572015
Highly efficient asymmetric amination of β-keto esters catalyzed by chiral quaternary ammonium bromides
Q Lan, X Wang, R He, C Ding, K Maruoka
Tetrahedron Letters 50 (26), 3280-3282, 2009
542009
Mycobacterial protein tyrosine phosphatases A and B inhibitors augment the bactericidal activity of the standard anti-tuberculosis regimen
NK Dutta, R He, ML Pinn, Y He, F Burrows, ZY Zhang, PC Karakousis
ACS infectious diseases 2 (3), 231-239, 2016
462016
Binaphthyl-modified quaternary phosphonium salts as chiral phase transfer catalysts: Application to asymmetric amination of β-Keto esters
R He, K Maruoka
Synthesis 2009 (13), 2289-2292, 2009
432009
A Base‐Free Neutral Phase‐Transfer Reaction System
S Shirakawa, L Wang, R He, S Arimitsu, K Maruoka
Chemistry–An Asian Journal 9 (6), 1586-1593, 2014
402014
Bicyclic benzofuran and indole-based salicylic acids as protein tyrosine phosphatase inhibitors
Y He, LF Zeng, ZH Yu, R He, S Liu, ZY Zhang
Bioorganic & medicinal chemistry 20 (6), 1940-1946, 2012
402012
Traceless solid-phase synthesis of substituted xanthines
R He, SM Ching, Y Lam
Journal of Combinatorial Chemistry 8 (6), 923-928, 2006
352006
Double click reaction for the acquisition of a highly potent and selective mPTPB inhibitor
R He, Z Yu, Y He, LF Zeng, J Xu, L Wu, AM Gunawan, L Wang, ZX Jiang, ...
ChemMedChem 5 (12), 2051-2056, 2010
302010
Stepwise construction of disulfides in peptides
R He, J Pan, JP Mayer, F Liu
ChemBioChem 21 (8), 1101-1111, 2020
292020
A Facile Hydroxyindole Carboxylic Acid Based Focused Library Approach for Potent and Selective Inhibitors of Mycobacterium Protein Tyrosine Phosphatase B
LF Zeng, J Xu, Y He, R He, L Wu, AM Gunawan, ZY Zhang
ChemMedChem 8 (6), 904-908, 2013
292013
CB1 and GLP-1 receptors cross talk provides new therapies for obesity
P Zizzari, R He, S Falk, L Bellocchio, C Allard, S Clark, T Lesté-Lasserre, ...
Diabetes 70 (2), 415-422, 2021
272021
Organocatalytic multicomponent reaction for the acquisition of a selective inhibitor of mPTPB, a virulence factor of tuberculosis
R He, LF Zeng, Y He, L Wu, AM Gunawan, ZY Zhang
Chemical communications 49 (20), 2064-2066, 2013
272013
The system can't perform the operation now. Try again later.
Articles 1–20